Blog

Pioneering Cancer Insights and Prevention Strategies – The Babak Lab

The Babak Lab/LinkedIn

Jul 21, 2024, 20:38

Pioneering Cancer Insights and Prevention Strategies – The Babak Lab

Maria Babak shared a post by on LinkedIn:

“Don’t miss out on these essential updates!

From the groundbreaking potential of prenatal screenings to the significant impact of diet on cancer risk and actionable tips to prevent up to 50% of cancer deaths, there’s a wealth of life-saving information here. Staying updated with these insights can empower you to make informed health decisions and support the broader fight against cancer.”

Quoting ‘s post:

“Weekly Digest: Pioneering Cancer Insights and Prevention Strategies

Stay Informed with the latest research and strategies in cancer detection and prevention. By understanding and acting on these insights, we can collectively work towards reducing cancer incidence and improving public health.

Call to Action for Oncologists: Managing Cancer Detected Through Prenatal Screening
Discover how prenatal screenings can incidentally detect maternal cancers, offering a life-saving opportunity. This highlights the need for oncologists to engage actively in these unexpected diagnoses, advocating for standardized care and follow-up protocols.

New Insights on Diet and Cancer Risk: The Mediating Role of Metabolites
Uncover the profound impact of dietary patterns like the Mediterranean and MIND diets on cancer risk. This study emphasizes the role of specific metabolites in mediating diet-cancer relationships, offering actionable insights for cancer prevention.

The Truth About Cancer Prevention: What Will It Take to End Cancer?
Gain clarity on cancer prevention myths and truths. This post distills decades of research into actionable tips that could prevent up to 50% of cancer deaths, addressing the crucial need for equitable access to preventive measures.”

Source: Maria Babak/LinkedIn and /LinkedIn

Dr. Maria (Masha) Babak is the Head of The Babak Lab and an Assistant Professor at the City University of Hong Kong. She earned her Ph.D. in bioinorganic chemistry from the University of Vienna in 2014. From 2015 to 2020, Dr. Babak was a postdoctoral research fellow at the National University of Singapore under the mentorship of Prof.

Wee Han Ang, where she developed a strong passion for drug discovery and drug target identification. In November 2020, she joined the City University of Hong Kong as an assistant professor. Dr. Babak received the Graeme Hanson-AsBIC Early Career Award in 2022.

Her research interests are at the intersection of chemistry, biology, and medicine, with a focus on the discovery and preclinical development of anticancer drugs for resistant and aggressive cancers with limited treatment options, such as malignant pleural mesothelioma and brain metastases.